Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma. [electronic resource]
Producer: 19971008Description: 1323-5 p. digitalISSN:- 0959-8049
- Adult
- Agranulocytosis -- chemically induced
- Amifostine -- therapeutic use
- Antineoplastic Agents, Alkylating -- adverse effects
- Bone Marrow -- drug effects
- Cyclophosphamide -- adverse effects
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Opportunistic Infections -- prevention & control
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.